Display options
Cite
Yuksel M, Gonul S, Laleci Erturkmen GB, et al. An Interoperability Platform Enabling Reuse of Electronic Health Records for Signal Verification Studies. Biomed Res Int. 2016;2016:6741418doi: 10.1155/2016/6741418.
Yuksel, M., Gonul, S., Laleci Erturkmen, G. B., Sinaci, A. A., Invernizzi, P., Facchinetti, S., Migliavacca, A., Bergvall, T., Depraetere, K., & De Roo, J. (2016). An Interoperability Platform Enabling Reuse of Electronic Health Records for Signal Verification Studies. BioMed research international, 20166741418. https://doi.org/10.1155/2016/6741418
Yuksel, Mustafa, et al. "An Interoperability Platform Enabling Reuse of Electronic Health Records for Signal Verification Studies." BioMed research international vol. 2016 (2016): 6741418. doi: https://doi.org/10.1155/2016/6741418
Yuksel M, Gonul S, Laleci Erturkmen GB, Sinaci AA, Invernizzi P, Facchinetti S, Migliavacca A, Bergvall T, Depraetere K, De Roo J. An Interoperability Platform Enabling Reuse of Electronic Health Records for Signal Verification Studies. Biomed Res Int. 2016;2016:6741418. doi: 10.1155/2016/6741418. Epub 2016 Mar 31. PMID: 27123451; PMCID: PMC4830705.
Copy Download .nbib Format: NLM
Share it on

Biomed Res Int. 2016;2016:6741418. doi: 10.1155/2016/6741418. Epub 2016 Mar 31.

An Interoperability Platform Enabling Reuse of Electronic Health Records for Signal Verification Studies.

BioMed research international

Mustafa Yuksel, Suat Gonul, Gokce Banu Laleci Erturkmen, Ali Anil Sinaci, Paolo Invernizzi, Sara Facchinetti, Andrea Migliavacca, Tomas Bergvall, Kristof Depraetere, Jos De Roo

Affiliations

  1. SRDC Software Research & Development and Consultancy Ltd., 06800 Ankara, Turkey.
  2. SRDC Software Research & Development and Consultancy Ltd., 06800 Ankara, Turkey; Department of Computer Engineering, Middle East Technical University, 06800 Ankara, Turkey.
  3. Lombardia Informatica S.p.A., Via Torquato Taramelli, 26 20124 Milano, Italy.
  4. WHO Collaborating Centre for International Drug Monitoring, Uppsala Monitoring Centre (UMC), 753 20 Uppsala, Sweden.
  5. Advanced Clinical Applications Research Group, Agfa HealthCare, 9000 Gent, Belgium.

PMID: 27123451 PMCID: PMC4830705 DOI: 10.1155/2016/6741418

Abstract

Depending mostly on voluntarily sent spontaneous reports, pharmacovigilance studies are hampered by low quantity and quality of patient data. Our objective is to improve postmarket safety studies by enabling safety analysts to seamlessly access a wide range of EHR sources for collecting deidentified medical data sets of selected patient populations and tracing the reported incidents back to original EHRs. We have developed an ontological framework where EHR sources and target clinical research systems can continue using their own local data models, interfaces, and terminology systems, while structural interoperability and Semantic Interoperability are handled through rule-based reasoning on formal representations of different models and terminology systems maintained in the SALUS Semantic Resource Set. SALUS Common Information Model at the core of this set acts as the common mediator. We demonstrate the capabilities of our framework through one of the SALUS safety analysis tools, namely, the Case Series Characterization Tool, which have been deployed on top of regional EHR Data Warehouse of the Lombardy Region containing about 1 billion records from 16 million patients and validated by several pharmacovigilance researchers with real-life cases. The results confirm significant improvements in signal detection and evaluation compared to traditional methods with the missing background information.

References

  1. J Am Med Inform Assoc. 2013 May 1;20(3):446-52 - PubMed
  2. J Biomed Inform. 2012 Aug;45(4):763-71 - PubMed
  3. J Biomed Inform. 2013 Oct;46(5):784-94 - PubMed
  4. IEEE J Biomed Health Inform. 2013 Mar;17(2):356-69 - PubMed
  5. Stat Med. 2002 Jul 30;21(14):2027-44 - PubMed
  6. J Am Med Inform Assoc. 2003 Mar-Apr;10(2):115-28 - PubMed
  7. Nucleic Acids Res. 2004 Jan 1;32(Database issue):D267-70 - PubMed
  8. Drug Saf. 2004;27(12):857-70 - PubMed
  9. Jt Comm J Qual Improv. 1995 Oct;21(10):541-8 - PubMed
  10. J Med Internet Res. 2005;7(1):e4 - PubMed
  11. J Investig Med. 2005 Dec;53(8):425-33 - PubMed
  12. Drug Saf. 2006;29(5):385-96 - PubMed
  13. J Am Med Inform Assoc. 2007 Sep-Oct;14(5):662-73 - PubMed
  14. Invest Ophthalmol Vis Sci. 2007 Oct;48(10):4383-9 - PubMed
  15. J Am Med Inform Assoc. 2008 Mar-Apr;15(2):130-7 - PubMed
  16. AMIA Annu Symp Proc. 2007;:216-20 - PubMed
  17. Methods Inf Med. 2009;48(1):38-44 - PubMed
  18. Methods Inf Med. 2009;48(1):45-54 - PubMed
  19. BMC Med Inform Decis Mak. 2009;9:5 - PubMed
  20. Health Informatics J. 2009 Jun;15(2):108-21 - PubMed
  21. J Am Med Inform Assoc. 2009 Sep-Oct;16(5):624-30 - PubMed
  22. Clin Med (Lond). 2009 Oct;9(5):486-9 - PubMed
  23. J Am Med Inform Assoc. 2010 Mar-Apr;17(2):124-30 - PubMed
  24. AMIA Annu Symp Proc. 2009;2009:391-5 - PubMed
  25. Stud Health Technol Inform. 2010;160(Pt 2):912-6 - PubMed
  26. Stud Health Technol Inform. 2010;160(Pt 2):1060-4 - PubMed
  27. Methods Inf Med. 2011;50(2):140-9 - PubMed
  28. J Biomed Inform. 2011 Apr;44(2):343-53 - PubMed
  29. Nucleic Acids Res. 2011 Jul;39(Web Server issue):W541-5 - PubMed
  30. Stud Health Technol Inform. 2011;169:734-8 - PubMed
  31. J Biomed Inform. 2011 Dec;44 Suppl 1:S94-102 - PubMed
  32. Stud Health Technol Inform. 2012;180:73-7 - PubMed
  33. J Am Med Inform Assoc. 2013 Sep-Oct;20(5):986-94 - PubMed

MeSH terms

Publication Types